SCOLR’s Extended-Release Ibuprofen Plans Ramp Up After Break With Wyeth

SCOLR Pharma plans to submit a new drug application for its extended-release ibuprofen to FDA in the latter half of 2008

More from Archive

More from Pink Sheet